To validate whether SOX30 acts as a functional miR-653-5p target in regulating prostate cancer cell proliferation, invasion and Wnt/β-catenin signaling, we determined the effect of SOX30 silencing on the miR-652-3p inhibition-mediated anti-tumor effect. This evidence concerns the gene SOX30 and prostate carcinoma.